¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : DCC Á¦2ȸÀÇÀå

±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  

À̸ÞÀÏ : urology@urology.or.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 110,000¿ø  

ºñ°í »çÀüµî·Ï Á¤È¸¿ø: 88,000¿ø ±ºÀÇ°ü/°øº¸ÀÇ: 44,000¿ø Àü°øÀÇ: 33,000¿ø ±¹Á¦È¸¿ø: 88,000¿ø °£È£»ç/¿¬±¸¿ø: 38,500¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±âȸ»ç Á÷¿ø/±âŸ: 110,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:00~13:20 ÃֽŠÀÇ·áÀΰøÁö´É ¿¬±¸µ¿Çâ ¹× ÀÓ»óÀÇÀÇ ¿ªÇÒ Á¤¼º¹®(°æºÏÀÇ´ë ÀÇ·áÁ¤º¸Çб³½Ç)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:20~13:40 ÀÇ·áÀΰøÁö´É ¿¬±¸¸¦ À§ÇÑ Áغñ ¹× ÀýÂ÷ Ã߹μö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:40~14:00 ÀǷ῵»ó ±â¹ÝÀÇ ÀΰøÁö´É ¿¬±¸ ±è¿µ°ï(¼­¿ïÀÇ´ë À¶ÇÕÀÇÇаú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:00~14:20 ºñ´¢±â ¿µ¿ª¿¡¼­ ÀΰøÁö´ÉÀÇ Àû¿ë»ç·Ê ±èÀÀÈñ(¶óÀÌÇÁ½Ã¸Çƽ½º)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:30~14:50 The role of I-O agents in non-metastatic urothelial carcinoma ÀÓ¹üÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:50~15:10 Peri-operative immunotherapy in high-risk, non-metastatic RCC Á¶Á¤±â(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:10~15:30 Management of I-O drug related complications in urologic cancer: sharing basic knowledge ÇÔ¿ø½Ä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:30~15:50 Management of I-O drug related complications in urologic cancer: sharing real clinical practice ±èÁÂÈÆ(°í·ÁÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:10~16:30 Management of low testosterone in prostate cancer survivors ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:30~16:50 Effects of COVID-19 on male sexual health ¾È¼øÅÂ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:50~17:10 Does Low intensity shockwave therapy have a role for urological diseases other than ED? ±è°­¼·(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 17:10~17:30 Office-based management of premature ejaculation ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦73Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-14
´ÙÀ½±Û 2023 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ ´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2023-04-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21167 ±¤ÁÖ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦85ȸ ±¤ÁÖ °³¿øÀÇ ¹× Àü°øÀÇ ¿¬¼ö°­Á : 2024-07-19 0 21 2024-07-01
21166 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-07-19 0 11 2024-07-01
21165 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-07-19 0 15 2024-07-01
21164 ÀüºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦299Â÷ ¿ù·ÊÁý´ãȸ : 2024-07-19 0 10 2024-07-01
21163 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-18 0 9 2024-07-01
21162 °æ±â ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-°æÀÎ(³²ºÎ) : 2024-07-16 0 9 2024-07-01
21161 ¼­¿ï 2024³â 1Â÷ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç ¿¬¼ö°­Á : 2024-07-14 0 8 2024-07-01
21160 ¼­¿ï 2024 Á¦16ȸ ´ëÇѼºÇü¿Ü°úÇÐȸ ´«¼ºÇü¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-14 0 8 2024-07-01
21159 ¼­¿ï Á¦11ȸ ´ëÇѺñ°úÇÐȸ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-14 0 13 2024-07-01
21158 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ 2024³â ⸳62ÁÖ³â±â³ä ½ÉÆ÷Áö¾ö : 2024-07-13 0 8 2024-07-01
21157 ¼­¿ï Á¦46ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2024-07-13 0 10 2024-07-01
21156 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 24³â ´ëµ¿¸Æ ½ÉÆ÷Áö¿ò : 2024-07-13 0 13 2024-07-01
21155 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Á¦18Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2024-07-13 0 4 2024-07-01
21154 ¼­¿ï 2024 ¿¬¼¼ÀÇ´ë Á¤Çü¿Ü°úÇб³½Ç ½ÉÆ÷Áö¿ò : ÃÖÁ¾Çõ ±³¼ö Á¤³â±â³ä : 2024-07-13 0 8 2024-07-01
21153 ¼­¿ï ´ëÇÑ¿Ü»óÁßȯÀÚ¿Ü°úÇÐȸ Á¦50Â÷ Áý´ãȸ (Management of upper & lower GI bleeding) : 2024-07-13 0 8 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷